Gene Therapy in Treating Women With Metastatic Breast Cancer
Completed · Phase 1
Conditions studied: Breast Cancer
In brief
RATIONALE: Placing the gene for interleukin-12 into breast cancer cells may help the body build an immune response to kill tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of gene therapy in treating women with metastatic breast cancer.
Key facts
- Study ID
- NCT00849459
- Run by
- Max Sung
- People needed
- 3
- Starts
- 2008-08-01
- Expected to finish
- 2011-06-01
- Last updated by the study team
- 2017-01-11
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Icahn Medical Center at Mount Sinai — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.